FilingSEC EDGAR6-K
Kazia Therapeutics Reduces ATM Offering Capacity to $80 Million
· SEC accepted
StageOngoing
Filing content
Kazia Therapeutics announced a reduction in the maximum aggregate offering price of ADSs under its sales agreement with Leerink Partners from $100 million to $80 million.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…